SlideShare a Scribd company logo
Management Of Adverse Drug
Reactions
Name:- Nevase Kumar Dipak.
Class :- Final Year B.Pharmacy
Roll No.:- 29
Guided By
Mrs Reshma V. Pawar
Associate Professor,
SPM’s College of Pharmacy,
Akluj
What is Adverse Drug Reaction ?
• Adverse Drug Reaction:- World Health Organization
(WHO) defined ADR as “A response which is noxious
and unintended, and which occurs at doses normally
used in humans for the prophylaxis, diagnosis, or therapy
of disease, or for the modification of physiological
function.”
• Adverse drug reactions (ADRs) are a leading cause of
morbidity and mortality, accounting for hospital
admissions and cost burden on the people.
• Elderly patients are at highest risk of experiencing
ADRs, many of which are preventable.
• The most commonly-implicated medications include:
Antibiotics, anticoagulants, digoxin, diuretics,
hypoglycemics, antineoplastics, and nonsteroidal anti-
inflammatory drugs, which are responsible about 60%
of hospital admissions.
Management Of Adverse Drug Reactions
• The main and primary step in management is
withdrawal of suspected drugs.
• However, in case the reaction is expected to be dose
related, then dose of the drug must be reduced, and
treatment for suspected reaction must be considered.
• When an adverse drug reaction is managed, clear
therapeutic objective must be maintained.
• The drug treatment must not be unnecessarily continued
for longer time period and the patient must be reviewed
regularly and simplify management should be followed.
Management Of Adverse Drug Reactions
• Following steps must be followed during the
management of any type of suspected, or unexpected
adverse drug reactions. :-
1. Monitoring patient who are at greater risk of
developing ADRs.
2. Monitoring patients who are prescribed with drugs
highly likely to cause ADRs.
3. Assessing and documenting the patient’s previous
allergic status.
4. Assessing patient’s drug therapy for its
appropriateness.
5. Changing dose of drug.
6. Replacement with alternate medicine.
Management Of Adverse Drug Reactions
7. Use of prophylactic regimen.
8. Assessing possible drug interactions in multiple
therapies.
9. Assistant health care professionals in the detection and
assessment of ADRs.
10. Stimulating health care professionals in reporting an
ADR.
11. Documentation of suspected reported reactions for
further references.
12. Obtaining feedback about the reported reaction.
13. Educating health care professionals about the
importance of reporting an ADR.
14. Educating patients
Management Of Adverse Drug Reactions
15. Creating awareness about ADRs amongst health care
professionals, patients and public.
16. Presentation of reports in meetings and conferences.
17. Conducting workshops or seminars or conferences on
ADRs for health care professionals.
Reference
A Book Of Pharmacovigilance
By Dr. Agnimitra Dinda, Monika Saxena.
Thakur Publication.
First Edition 2021
Page No. 43-44.

More Related Content

What's hot

Spontaneous Reporting System
Spontaneous Reporting SystemSpontaneous Reporting System
Spontaneous Reporting System
Jasdeep singh brar
 
Prescription event monitoring
Prescription event monitoringPrescription event monitoring
Prescription event monitoring
Reyaz Bhat
 
WHO International Drug Monitoring Program
WHO International Drug Monitoring ProgramWHO International Drug Monitoring Program
WHO International Drug Monitoring Program
SnehaKhandale1
 
Adverse drug reaction monitoring and reporting
Adverse drug reaction monitoring and reportingAdverse drug reaction monitoring and reporting
Adverse drug reaction monitoring and reporting
THUSHARA MOHAN
 
Management of adverse drug reactions
Management of adverse drug reactionsManagement of adverse drug reactions
Management of adverse drug reactions
ReshmaManeDeshmukh
 
Unit 1 pharmacoepidemiology
Unit 1 pharmacoepidemiologyUnit 1 pharmacoepidemiology
Unit 1 pharmacoepidemiology
Dr. Supriya Suman
 
Severity, seriousness, predictability and preventability assessment
Severity, seriousness, predictability and preventability assessmentSeverity, seriousness, predictability and preventability assessment
Severity, seriousness, predictability and preventability assessment
Dr. Ramesh Bhandari
 
Pharmacovigilance program of India (PvPI)
Pharmacovigilance program of India (PvPI)Pharmacovigilance program of India (PvPI)
Pharmacovigilance program of India (PvPI)
SnehaKhandale1
 
Establishment of Pharmacovigilance Programme
Establishment of Pharmacovigilance ProgrammeEstablishment of Pharmacovigilance Programme
Establishment of Pharmacovigilance Programme
Nipun Gupta
 
Definition and scope of Pharmacoepidemiology
Definition and scope of Pharmacoepidemiology Definition and scope of Pharmacoepidemiology
Definition and scope of Pharmacoepidemiology
ABUBAKRANSARI2
 
WHO international drug monitoring programme.pptx
WHO international drug monitoring programme.pptxWHO international drug monitoring programme.pptx
WHO international drug monitoring programme.pptx
ReshmaManeDeshmukh
 
ICH Guidelines for Pharmacovigilance
ICH Guidelines for PharmacovigilanceICH Guidelines for Pharmacovigilance
ICH Guidelines for Pharmacovigilance
Dr. Ramesh Bhandari
 
INTERNATIONAL NON PROPRIETARY NAMES FOR DRUGS1.pptx
INTERNATIONAL NON PROPRIETARY NAMES FOR DRUGS1.pptxINTERNATIONAL NON PROPRIETARY NAMES FOR DRUGS1.pptx
INTERNATIONAL NON PROPRIETARY NAMES FOR DRUGS1.pptx
E Poovarasan
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
Fariha Shikoh
 
Causality assessment scale
Causality assessment scaleCausality assessment scale
Causality assessment scale
drarunsingh4
 
CONTRACT RESEARCH ORGANIZATION
CONTRACT RESEARCH ORGANIZATIONCONTRACT RESEARCH ORGANIZATION
Vaccine safety surveillance
Vaccine safety surveillanceVaccine safety surveillance
Vaccine safety surveillance
Dr Priyanka Goswami
 
ADR AND ITS MONITORING
ADR  AND  ITS MONITORING ADR  AND  ITS MONITORING
ADR AND ITS MONITORING
abhishek mondal
 
Causality Assessment in Pharmacovigilance
Causality Assessment in PharmacovigilanceCausality Assessment in Pharmacovigilance
Causality Assessment in Pharmacovigilance
ClinosolIndia
 
CIOMS (1).pptx
CIOMS (1).pptxCIOMS (1).pptx
CIOMS (1).pptx
Sanjay522244
 

What's hot (20)

Spontaneous Reporting System
Spontaneous Reporting SystemSpontaneous Reporting System
Spontaneous Reporting System
 
Prescription event monitoring
Prescription event monitoringPrescription event monitoring
Prescription event monitoring
 
WHO International Drug Monitoring Program
WHO International Drug Monitoring ProgramWHO International Drug Monitoring Program
WHO International Drug Monitoring Program
 
Adverse drug reaction monitoring and reporting
Adverse drug reaction monitoring and reportingAdverse drug reaction monitoring and reporting
Adverse drug reaction monitoring and reporting
 
Management of adverse drug reactions
Management of adverse drug reactionsManagement of adverse drug reactions
Management of adverse drug reactions
 
Unit 1 pharmacoepidemiology
Unit 1 pharmacoepidemiologyUnit 1 pharmacoepidemiology
Unit 1 pharmacoepidemiology
 
Severity, seriousness, predictability and preventability assessment
Severity, seriousness, predictability and preventability assessmentSeverity, seriousness, predictability and preventability assessment
Severity, seriousness, predictability and preventability assessment
 
Pharmacovigilance program of India (PvPI)
Pharmacovigilance program of India (PvPI)Pharmacovigilance program of India (PvPI)
Pharmacovigilance program of India (PvPI)
 
Establishment of Pharmacovigilance Programme
Establishment of Pharmacovigilance ProgrammeEstablishment of Pharmacovigilance Programme
Establishment of Pharmacovigilance Programme
 
Definition and scope of Pharmacoepidemiology
Definition and scope of Pharmacoepidemiology Definition and scope of Pharmacoepidemiology
Definition and scope of Pharmacoepidemiology
 
WHO international drug monitoring programme.pptx
WHO international drug monitoring programme.pptxWHO international drug monitoring programme.pptx
WHO international drug monitoring programme.pptx
 
ICH Guidelines for Pharmacovigilance
ICH Guidelines for PharmacovigilanceICH Guidelines for Pharmacovigilance
ICH Guidelines for Pharmacovigilance
 
INTERNATIONAL NON PROPRIETARY NAMES FOR DRUGS1.pptx
INTERNATIONAL NON PROPRIETARY NAMES FOR DRUGS1.pptxINTERNATIONAL NON PROPRIETARY NAMES FOR DRUGS1.pptx
INTERNATIONAL NON PROPRIETARY NAMES FOR DRUGS1.pptx
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 
Causality assessment scale
Causality assessment scaleCausality assessment scale
Causality assessment scale
 
CONTRACT RESEARCH ORGANIZATION
CONTRACT RESEARCH ORGANIZATIONCONTRACT RESEARCH ORGANIZATION
CONTRACT RESEARCH ORGANIZATION
 
Vaccine safety surveillance
Vaccine safety surveillanceVaccine safety surveillance
Vaccine safety surveillance
 
ADR AND ITS MONITORING
ADR  AND  ITS MONITORING ADR  AND  ITS MONITORING
ADR AND ITS MONITORING
 
Causality Assessment in Pharmacovigilance
Causality Assessment in PharmacovigilanceCausality Assessment in Pharmacovigilance
Causality Assessment in Pharmacovigilance
 
CIOMS (1).pptx
CIOMS (1).pptxCIOMS (1).pptx
CIOMS (1).pptx
 

Similar to Managment of Adverse Drug Reactions

Reporting and Management of Adverse Drug Reaction
Reporting and Management of Adverse Drug ReactionReporting and Management of Adverse Drug Reaction
Reporting and Management of Adverse Drug Reaction
Soniya Sunil
 
Medication Safety- Administration and monitoring.pptx
Medication Safety- Administration and monitoring.pptxMedication Safety- Administration and monitoring.pptx
Medication Safety- Administration and monitoring.pptx
Latha Venkatesan
 
ADR, Monitoring& Reporting.pptx
ADR, Monitoring& Reporting.pptxADR, Monitoring& Reporting.pptx
ADR, Monitoring& Reporting.pptx
Merlin Dinesh
 
1591115199267_Pharmacovigilance.pptx
1591115199267_Pharmacovigilance.pptx1591115199267_Pharmacovigilance.pptx
1591115199267_Pharmacovigilance.pptx
DrAniqaSundas
 
Polypharmacy and Rational Prescribing in Elderly Patients.pptx
Polypharmacy and Rational Prescribing in Elderly Patients.pptxPolypharmacy and Rational Prescribing in Elderly Patients.pptx
Polypharmacy and Rational Prescribing in Elderly Patients.pptx
Ahmed Mshari
 
ADR and pharmacovigillance
ADR and pharmacovigillanceADR and pharmacovigillance
ADR and pharmacovigillance
NesNalNiraula1
 
Adverse drug reaction bpharm 7th sem notes
Adverse drug reaction bpharm 7th sem notesAdverse drug reaction bpharm 7th sem notes
Adverse drug reaction bpharm 7th sem notes
Prathikshakotari
 
ADRppt.pptx
ADRppt.pptxADRppt.pptx
ADRppt.pptx
Niyasp8
 
Adverse Drug Reactions
Adverse Drug ReactionsAdverse Drug Reactions
Adverse Drug Reactions
Kajal Rajdev
 
intro of adr.pptx
intro of adr.pptxintro of adr.pptx
intro of adr.pptx
GayatriBahatkar1
 
CLINICAL PHARMACY.pptx
CLINICAL PHARMACY.pptxCLINICAL PHARMACY.pptx
CLINICAL PHARMACY.pptx
Archana Chavhan
 
Spontaneous reporting schemes for biodrug adverse reactions,
Spontaneous reporting schemes for biodrug adverse reactions,Spontaneous reporting schemes for biodrug adverse reactions,
Spontaneous reporting schemes for biodrug adverse reactions,
Vishwajeet Upadhye
 
Optimising Medicine Use, Professor Graham Davies, King's College London
Optimising Medicine Use, Professor Graham Davies, King's College LondonOptimising Medicine Use, Professor Graham Davies, King's College London
Optimising Medicine Use, Professor Graham Davies, King's College London
KCL_commsunit
 
Clinical Pharmacy
Clinical PharmacyClinical Pharmacy
Clinical Pharmacy
sunayanamali
 
Adverse drug reaction
Adverse drug reactionAdverse drug reaction
Adverse drug reaction
Prajjwal Rajput
 
Clinical pharmacy services
Clinical pharmacy services Clinical pharmacy services
Clinical pharmacy services
SendhilKumar74
 
Pharmaceutical care concepts - clinical pharmacy
Pharmaceutical care concepts - clinical pharmacy Pharmaceutical care concepts - clinical pharmacy
Pharmaceutical care concepts - clinical pharmacy
ShaistaSumayya
 
clinical pharmacy .pptx
clinical pharmacy .pptxclinical pharmacy .pptx
clinical pharmacy .pptx
AjithJs2
 
Medication Adherence
Medication Adherence Medication Adherence
Medication Adherence
sunayanamali
 
RUD and COMPLIANCE
RUD and COMPLIANCERUD and COMPLIANCE
RUD and COMPLIANCE
DeepakGadade
 

Similar to Managment of Adverse Drug Reactions (20)

Reporting and Management of Adverse Drug Reaction
Reporting and Management of Adverse Drug ReactionReporting and Management of Adverse Drug Reaction
Reporting and Management of Adverse Drug Reaction
 
Medication Safety- Administration and monitoring.pptx
Medication Safety- Administration and monitoring.pptxMedication Safety- Administration and monitoring.pptx
Medication Safety- Administration and monitoring.pptx
 
ADR, Monitoring& Reporting.pptx
ADR, Monitoring& Reporting.pptxADR, Monitoring& Reporting.pptx
ADR, Monitoring& Reporting.pptx
 
1591115199267_Pharmacovigilance.pptx
1591115199267_Pharmacovigilance.pptx1591115199267_Pharmacovigilance.pptx
1591115199267_Pharmacovigilance.pptx
 
Polypharmacy and Rational Prescribing in Elderly Patients.pptx
Polypharmacy and Rational Prescribing in Elderly Patients.pptxPolypharmacy and Rational Prescribing in Elderly Patients.pptx
Polypharmacy and Rational Prescribing in Elderly Patients.pptx
 
ADR and pharmacovigillance
ADR and pharmacovigillanceADR and pharmacovigillance
ADR and pharmacovigillance
 
Adverse drug reaction bpharm 7th sem notes
Adverse drug reaction bpharm 7th sem notesAdverse drug reaction bpharm 7th sem notes
Adverse drug reaction bpharm 7th sem notes
 
ADRppt.pptx
ADRppt.pptxADRppt.pptx
ADRppt.pptx
 
Adverse Drug Reactions
Adverse Drug ReactionsAdverse Drug Reactions
Adverse Drug Reactions
 
intro of adr.pptx
intro of adr.pptxintro of adr.pptx
intro of adr.pptx
 
CLINICAL PHARMACY.pptx
CLINICAL PHARMACY.pptxCLINICAL PHARMACY.pptx
CLINICAL PHARMACY.pptx
 
Spontaneous reporting schemes for biodrug adverse reactions,
Spontaneous reporting schemes for biodrug adverse reactions,Spontaneous reporting schemes for biodrug adverse reactions,
Spontaneous reporting schemes for biodrug adverse reactions,
 
Optimising Medicine Use, Professor Graham Davies, King's College London
Optimising Medicine Use, Professor Graham Davies, King's College LondonOptimising Medicine Use, Professor Graham Davies, King's College London
Optimising Medicine Use, Professor Graham Davies, King's College London
 
Clinical Pharmacy
Clinical PharmacyClinical Pharmacy
Clinical Pharmacy
 
Adverse drug reaction
Adverse drug reactionAdverse drug reaction
Adverse drug reaction
 
Clinical pharmacy services
Clinical pharmacy services Clinical pharmacy services
Clinical pharmacy services
 
Pharmaceutical care concepts - clinical pharmacy
Pharmaceutical care concepts - clinical pharmacy Pharmaceutical care concepts - clinical pharmacy
Pharmaceutical care concepts - clinical pharmacy
 
clinical pharmacy .pptx
clinical pharmacy .pptxclinical pharmacy .pptx
clinical pharmacy .pptx
 
Medication Adherence
Medication Adherence Medication Adherence
Medication Adherence
 
RUD and COMPLIANCE
RUD and COMPLIANCERUD and COMPLIANCE
RUD and COMPLIANCE
 

More from ReshmaManeDeshmukh

2.3  Daily defined doses.pptx
2.3  Daily defined doses.pptx2.3  Daily defined doses.pptx
2.3  Daily defined doses.pptx
ReshmaManeDeshmukh
 
International classification of diseases.pptx
International classification of diseases.pptxInternational classification of diseases.pptx
International classification of diseases.pptx
ReshmaManeDeshmukh
 
Anatomical, therapeutic and chemical classification of drugs.pptx
 Anatomical, therapeutic and chemical classification of drugs.pptx Anatomical, therapeutic and chemical classification of drugs.pptx
Anatomical, therapeutic and chemical classification of drugs.pptx
ReshmaManeDeshmukh
 
severity and seriousness.pptx
severity and seriousness.pptxseverity and seriousness.pptx
severity and seriousness.pptx
ReshmaManeDeshmukh
 
Pharmacovigilance Program of India(PvPI).pptx
Pharmacovigilance Program of India(PvPI).pptxPharmacovigilance Program of India(PvPI).pptx
Pharmacovigilance Program of India(PvPI).pptx
ReshmaManeDeshmukh
 
1.2 Importance of safety monitoring of Medicine.pptx
1.2 Importance of safety monitoring of Medicine.pptx1.2 Importance of safety monitoring of Medicine.pptx
1.2 Importance of safety monitoring of Medicine.pptx
ReshmaManeDeshmukh
 
International Classification of Disease
International Classification of Disease International Classification of Disease
International Classification of Disease
ReshmaManeDeshmukh
 
Methods in causality assessment.pptx
Methods in causality assessment.pptxMethods in causality assessment.pptx
Methods in causality assessment.pptx
ReshmaManeDeshmukh
 
Detection and Reporting of Adverse Reaction
Detection and Reporting of Adverse Reaction Detection and Reporting of Adverse Reaction
Detection and Reporting of Adverse Reaction
ReshmaManeDeshmukh
 
Fibrinolytics.pptx
Fibrinolytics.pptxFibrinolytics.pptx
Fibrinolytics.pptx
ReshmaManeDeshmukh
 
diuretics.pptx
diuretics.pptxdiuretics.pptx
diuretics.pptx
ReshmaManeDeshmukh
 
Coagulants.pptx
Coagulants.pptxCoagulants.pptx
Coagulants.pptx
ReshmaManeDeshmukh
 
Antihyperlipidemic drugs.pptx
Antihyperlipidemic drugs.pptxAntihyperlipidemic drugs.pptx
Antihyperlipidemic drugs.pptx
ReshmaManeDeshmukh
 
History and development of pharmacovigilance.pptx
History and development of pharmacovigilance.pptxHistory and development of pharmacovigilance.pptx
History and development of pharmacovigilance.pptx
ReshmaManeDeshmukh
 
antianginal drug.pptx
antianginal drug.pptxantianginal drug.pptx
antianginal drug.pptx
ReshmaManeDeshmukh
 
Antiarrthymic drug.pptx
Antiarrthymic drug.pptxAntiarrthymic drug.pptx
Antiarrthymic drug.pptx
ReshmaManeDeshmukh
 
Renal Complication And Their Herbal Remedy final.pptx
Renal Complication And Their Herbal Remedy final.pptxRenal Complication And Their Herbal Remedy final.pptx
Renal Complication And Their Herbal Remedy final.pptx
ReshmaManeDeshmukh
 

More from ReshmaManeDeshmukh (17)

2.3  Daily defined doses.pptx
2.3  Daily defined doses.pptx2.3  Daily defined doses.pptx
2.3  Daily defined doses.pptx
 
International classification of diseases.pptx
International classification of diseases.pptxInternational classification of diseases.pptx
International classification of diseases.pptx
 
Anatomical, therapeutic and chemical classification of drugs.pptx
 Anatomical, therapeutic and chemical classification of drugs.pptx Anatomical, therapeutic and chemical classification of drugs.pptx
Anatomical, therapeutic and chemical classification of drugs.pptx
 
severity and seriousness.pptx
severity and seriousness.pptxseverity and seriousness.pptx
severity and seriousness.pptx
 
Pharmacovigilance Program of India(PvPI).pptx
Pharmacovigilance Program of India(PvPI).pptxPharmacovigilance Program of India(PvPI).pptx
Pharmacovigilance Program of India(PvPI).pptx
 
1.2 Importance of safety monitoring of Medicine.pptx
1.2 Importance of safety monitoring of Medicine.pptx1.2 Importance of safety monitoring of Medicine.pptx
1.2 Importance of safety monitoring of Medicine.pptx
 
International Classification of Disease
International Classification of Disease International Classification of Disease
International Classification of Disease
 
Methods in causality assessment.pptx
Methods in causality assessment.pptxMethods in causality assessment.pptx
Methods in causality assessment.pptx
 
Detection and Reporting of Adverse Reaction
Detection and Reporting of Adverse Reaction Detection and Reporting of Adverse Reaction
Detection and Reporting of Adverse Reaction
 
Fibrinolytics.pptx
Fibrinolytics.pptxFibrinolytics.pptx
Fibrinolytics.pptx
 
diuretics.pptx
diuretics.pptxdiuretics.pptx
diuretics.pptx
 
Coagulants.pptx
Coagulants.pptxCoagulants.pptx
Coagulants.pptx
 
Antihyperlipidemic drugs.pptx
Antihyperlipidemic drugs.pptxAntihyperlipidemic drugs.pptx
Antihyperlipidemic drugs.pptx
 
History and development of pharmacovigilance.pptx
History and development of pharmacovigilance.pptxHistory and development of pharmacovigilance.pptx
History and development of pharmacovigilance.pptx
 
antianginal drug.pptx
antianginal drug.pptxantianginal drug.pptx
antianginal drug.pptx
 
Antiarrthymic drug.pptx
Antiarrthymic drug.pptxAntiarrthymic drug.pptx
Antiarrthymic drug.pptx
 
Renal Complication And Their Herbal Remedy final.pptx
Renal Complication And Their Herbal Remedy final.pptxRenal Complication And Their Herbal Remedy final.pptx
Renal Complication And Their Herbal Remedy final.pptx
 

Recently uploaded

HEAT WAVE presented by priya bhojwani..pptx
HEAT WAVE presented by priya bhojwani..pptxHEAT WAVE presented by priya bhojwani..pptx
HEAT WAVE presented by priya bhojwani..pptx
priyabhojwani1200
 
CONSTRUCTION OF TEST IN MANAGEMENT .docx
CONSTRUCTION OF TEST IN MANAGEMENT .docxCONSTRUCTION OF TEST IN MANAGEMENT .docx
CONSTRUCTION OF TEST IN MANAGEMENT .docx
PGIMS Rohtak
 
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondEmpowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Health Catalyst
 
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
ILC- UK
 
Telehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptxTelehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptx
The Harvest Clinic
 
Navigating Healthcare with Telemedicine
Navigating Healthcare with  TelemedicineNavigating Healthcare with  Telemedicine
Navigating Healthcare with Telemedicine
Iris Thiele Isip-Tan
 
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
Ameena Kadar
 
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
Kumar Satyam
 
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfCHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
Sachin Sharma
 
The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........
TheDocs
 
Health Education on prevention of hypertension
Health Education on prevention of hypertensionHealth Education on prevention of hypertension
Health Education on prevention of hypertension
Radhika kulvi
 
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICEJaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
ranishasharma67
 
Myopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptxMyopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptx
RitonDeb1
 
A Community health , health for prisoners
A Community health  , health for prisonersA Community health  , health for prisoners
A Community health , health for prisoners
Ahmed Elmi
 
Antibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptxAntibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptx
AnushriSrivastav
 
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Guillermo Rivera
 
CANCER CANCER CANCER CANCER CANCER CANCER
CANCER  CANCER  CANCER  CANCER  CANCER CANCERCANCER  CANCER  CANCER  CANCER  CANCER CANCER
CANCER CANCER CANCER CANCER CANCER CANCER
KRISTELLEGAMBOA2
 
ventilator, child on ventilator, newborn
ventilator, child on ventilator, newbornventilator, child on ventilator, newborn
ventilator, child on ventilator, newborn
Pooja Rani
 
💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...
💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...
💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...
ranishasharma67
 
Roti bank chennai PPT [Autosaved].pptx1
Roti bank  chennai PPT [Autosaved].pptx1Roti bank  chennai PPT [Autosaved].pptx1
Roti bank chennai PPT [Autosaved].pptx1
roti bank
 

Recently uploaded (20)

HEAT WAVE presented by priya bhojwani..pptx
HEAT WAVE presented by priya bhojwani..pptxHEAT WAVE presented by priya bhojwani..pptx
HEAT WAVE presented by priya bhojwani..pptx
 
CONSTRUCTION OF TEST IN MANAGEMENT .docx
CONSTRUCTION OF TEST IN MANAGEMENT .docxCONSTRUCTION OF TEST IN MANAGEMENT .docx
CONSTRUCTION OF TEST IN MANAGEMENT .docx
 
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondEmpowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
 
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
 
Telehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptxTelehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptx
 
Navigating Healthcare with Telemedicine
Navigating Healthcare with  TelemedicineNavigating Healthcare with  Telemedicine
Navigating Healthcare with Telemedicine
 
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
 
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
 
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfCHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
 
The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........
 
Health Education on prevention of hypertension
Health Education on prevention of hypertensionHealth Education on prevention of hypertension
Health Education on prevention of hypertension
 
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICEJaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
 
Myopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptxMyopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptx
 
A Community health , health for prisoners
A Community health  , health for prisonersA Community health  , health for prisoners
A Community health , health for prisoners
 
Antibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptxAntibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptx
 
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
 
CANCER CANCER CANCER CANCER CANCER CANCER
CANCER  CANCER  CANCER  CANCER  CANCER CANCERCANCER  CANCER  CANCER  CANCER  CANCER CANCER
CANCER CANCER CANCER CANCER CANCER CANCER
 
ventilator, child on ventilator, newborn
ventilator, child on ventilator, newbornventilator, child on ventilator, newborn
ventilator, child on ventilator, newborn
 
💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...
💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...
💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...
 
Roti bank chennai PPT [Autosaved].pptx1
Roti bank  chennai PPT [Autosaved].pptx1Roti bank  chennai PPT [Autosaved].pptx1
Roti bank chennai PPT [Autosaved].pptx1
 

Managment of Adverse Drug Reactions

  • 1. Management Of Adverse Drug Reactions Name:- Nevase Kumar Dipak. Class :- Final Year B.Pharmacy Roll No.:- 29 Guided By Mrs Reshma V. Pawar Associate Professor, SPM’s College of Pharmacy, Akluj
  • 2. What is Adverse Drug Reaction ? • Adverse Drug Reaction:- World Health Organization (WHO) defined ADR as “A response which is noxious and unintended, and which occurs at doses normally used in humans for the prophylaxis, diagnosis, or therapy of disease, or for the modification of physiological function.” • Adverse drug reactions (ADRs) are a leading cause of morbidity and mortality, accounting for hospital admissions and cost burden on the people.
  • 3. • Elderly patients are at highest risk of experiencing ADRs, many of which are preventable. • The most commonly-implicated medications include: Antibiotics, anticoagulants, digoxin, diuretics, hypoglycemics, antineoplastics, and nonsteroidal anti- inflammatory drugs, which are responsible about 60% of hospital admissions.
  • 4. Management Of Adverse Drug Reactions • The main and primary step in management is withdrawal of suspected drugs. • However, in case the reaction is expected to be dose related, then dose of the drug must be reduced, and treatment for suspected reaction must be considered. • When an adverse drug reaction is managed, clear therapeutic objective must be maintained. • The drug treatment must not be unnecessarily continued for longer time period and the patient must be reviewed regularly and simplify management should be followed.
  • 5. Management Of Adverse Drug Reactions • Following steps must be followed during the management of any type of suspected, or unexpected adverse drug reactions. :- 1. Monitoring patient who are at greater risk of developing ADRs. 2. Monitoring patients who are prescribed with drugs highly likely to cause ADRs. 3. Assessing and documenting the patient’s previous allergic status. 4. Assessing patient’s drug therapy for its appropriateness. 5. Changing dose of drug. 6. Replacement with alternate medicine.
  • 6. Management Of Adverse Drug Reactions 7. Use of prophylactic regimen. 8. Assessing possible drug interactions in multiple therapies. 9. Assistant health care professionals in the detection and assessment of ADRs. 10. Stimulating health care professionals in reporting an ADR. 11. Documentation of suspected reported reactions for further references. 12. Obtaining feedback about the reported reaction. 13. Educating health care professionals about the importance of reporting an ADR. 14. Educating patients
  • 7. Management Of Adverse Drug Reactions 15. Creating awareness about ADRs amongst health care professionals, patients and public. 16. Presentation of reports in meetings and conferences. 17. Conducting workshops or seminars or conferences on ADRs for health care professionals.
  • 8. Reference A Book Of Pharmacovigilance By Dr. Agnimitra Dinda, Monika Saxena. Thakur Publication. First Edition 2021 Page No. 43-44.